CD274 and neoplasm: In vivo experiments showed that both miR-142-5p-NBs+US and NKP-1339/miR-142-NBs+US treatments considerably reduced PD-L1 expression in tumor tissues (Fig. S2H), consistent with the WB and qPCR results (Fig. S2I to L).